Tumor Necrosis Factor Alpha (−238 / −308) and TNFRII-VNTR (−322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pathology and Oncology Research

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12253-014-9826-2PMID 25113639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RETRACTED ARTICLE: Impact of Toll-Like Receptors 2/3/4/9, IL-1-α/β and TNF-α Polymorphisms in Cervical Cancer Susceptibility in Tunisia

  2018cited by this paper
• A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer

  2013cited by this paper
• Susceptibility to cervical cancer: an overview.

  2012cited by this paper
• Association of TNF-α-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis.

  2012cited by this paper
• TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population

  2012cited by this paper
• Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis

  2012cited by this paper
• Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina).

  2012cited by this paper
• TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk

  2012cited by this paper
• Tumor necrosis factor biologics beyond psoriasis in dermatology

  2011cited by this paper
• Tumor necrosis factor superfamily molecules in acute coronary syndromes

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Tumor Necrosis Factor &agr; −308 G>A Polymorphisms and Cervical Cancer Risk: A Meta-Analysis

  2011cited by this paper
• TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses

  2011cited by this paper
• Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis.

  2011cited by this paper
• Molecular pathogenesis of cervical cancer

  2011cited by this paper
• Association of TNF-α Gene Promoter Polymorphisms With Susceptibility of Cervical Cancer in Southwest China

  2011cited by this paper
• Tumour Necrosis Factor Gene Polymorphism and Disease Prevalence

  2011cited by this paper
• Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

  2010cited by this paper
• Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.

  2009cited by this paper
• The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting

  2008cited by this paper
• Human papillomaviruses, cervical cancer and cell polarity

  2008cited by this paper
• TNFα–308G/A Polymorphism as a Risk Factor for HPV Associated Cervical Cancer in Indian Population

  2007cited by this paper
• The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women

  2006cited by this paper
• G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer

  2005cited by this paper
• TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.

  2005cited by this paper
• G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer.

  2005cited by this paper
• TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.

  2005cited by this paper
• TP73 alterations in cervical carcinoma.

  2004cited by this paper
• The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population.

  2004cited by this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cited by this paper
• Ursolic Acid Inhibits Nuclear Factor-κB Activation Induced by Carcinogenic Agents through Suppression of IκBα Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1

  2003cited by this paper
• TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.

  2003cited by this paper
• Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.

  2003cited by this paper
• Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

  2003cited by this paper
• Polymorphism at the –308‐promoter position of the tumor necrosis factor‐alpha (TNF‐α) gene and cervical cancer

  2003cited by this paper
• Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.

  2002cited by this paper
• Host genetic polymorphism analysis in cervical cancer.

  2002cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers.

  2001cited by this paper
• Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha.

  2001cited by this paper
• Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.

  2001cited by this paper
• A bi-allelic VNTR in the human TNFR2 (p75) gene promoter

  1999cited by this paper
• ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms.

  1999cited by this paper
• FIGO staging of gynecologic cancer

  1999cited by this paper
• ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms

  1999cited by this paper
• Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer.

  1998cited by this paper
• Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells.

  1998cited by this paper
• Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

  1997cited by this paper
• Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation (geneticsymajor histocompatibility complexycytokineygene regulationyautoimmune diseases)

  1997cited by this paper
• The tumor necrosis factor ligand and receptor families.

  1996cited by this paper
• TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense.

  1996cited by this paper
• Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases.

  1995cited by this paper
• Identification and characterization of a novel repressor site in the human tumor necrosis factor α gene

  1994cited by this paper
• Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene.

  1994cited by this paper
• Induction of tumor necrosis factor-alpha in murine Candida albicans infection.

  1993cited by this paper
• Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

  1993cited by this paper
• Induction of Tumor Necrosis Factor-α in Murine Candida albicans Infection

  1993cited by this paper
• Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.

  1992cited by this paper
• Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

  1990cited by this paper

• A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.

  2026cites this paper
• Evaluation of the Association of TNF‐α rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case‐Control Study and Meta‐Analysis

  2025cites this paper
• Assessing tumor necrosis factor-α (-238 G/A and -308 G/A) genetic polymorphisms in sepsis susceptibility among cystic fibrosis patients

  2025cites this paper
• The association of the TNFα gene rs1800629 and TLR3 gene rs3775291 polymorphisms with cervical cancer risk and its survival outcomes

  2025cites this paper
• Association between tumour necrosis factor-a polymorphism and cervical cancer in Lagos State, Nigeria

  2025cites this paper
• A Comprehensive Integration of Data Regarding the Correlation of TNF-α rs1800629 Polymorphism with Susceptibility to Cervical Cancer

  2024cites this paper
• IL-10 and TNF-α genes polymorphisms and the development of cervical lesions and cervical adenocarcinoma: a case-control study.

  2022cites this paper
• Polymorphisms in TNF-α/TNFR1 pathway genes are associated with CD4+ T cells recovery in HIV-1-infected individuals on antiretroviral therapy.

  2021cites this paper
• The Association of TNF-α Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population

  2021cites this paper
• TNF-α-308A>G and IL-10-819C>T polymorphisms as risk factors for cervical cancer: A case-control study, meta-analysis and trial sequential analysis

  2021cites this paper
• Immune response, inflammation pathway gene polymorphisms, and the risk of cervical cancer

  2021cites this paper
• A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma

  2021cites this paper
• Genetic variants association with cancers in African-based populations: A systematic review.

  2020cites this paper
• Incidence and risk factors associated with cervical cancer in sub-Saharan Africa: A systematic review

  2020cites this paper
• Genetic polymorphisms in tumor necrosis factor alpha and interleukin‐10 are associated with an increased risk of cervical cancer

  2019cites this paper
• Transcriptome changes induced by RUNX3 in cervical cancer cells in vitro

  2019cites this paper
• Association of CTLA‐4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma

  2019cites this paper
• Association of TNF-α-308 G > A Polymorphism with Susceptibility to Cervical Cancer and Breast Cancer –

  2019cites this paper
• MicroRNA‐92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer

  2018cites this paper
• Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers?

  2018cites this paper
• Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study

  2017cites this paper
• Association of tumor necrosis factor alpha polymorphisms with cervical cancer in a Chinese population

  2016cites this paper